Success Story

Innervace launches with $40M to repair the brain

Innervace, a regenerative medicine startup cofounded by Penn Medicine’s Kacy Cullen, PhD and Douglas Smith, PhD, raised up to $40 million in Series A financing.  The company is developing the first implantable biofabricated neural pathway to restore brain circuitry. The new funding is led by Deerfield Management with participation from founding investor IP Group, Inc., in addition to Penn Medicine, WARF Ventures, and BioAdvance will accelerate efforts to develop Innervace’s lead program, which aims to reconstruct the lost nigrostriatal pathway in patients with Parkinson’s Disease. Using these cells and a biofabricated scaffold pathway reconstruction strategy differentiates Innervace’s approach from current cell therapy approaches for Parkinson’s.

Skip to content